Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 74,983 | 63,546 | 20,206 | 10,426 | 31,875 |
| Depreciation Amortization | 92 | 73 | 43 | 77 | 299 |
| Income taxes - deferred | -32,971 | -31,347 | 0 | 0 | N/A |
| Accounts receivable | 4,549 | 4,665 | 3,775 | 3,618 | -10,537 |
| Accounts payable and accrued liabilities | 138 | -2,112 | 1,687 | -2,770 | 1,780 |
| Other Working Capital | -4,112 | -5,904 | -3,802 | -4,890 | -1,096 |
| Other Operating Activity | 2,355 | 3,008 | -1,431 | 752 | 12,291 |
| Operating Cash Flow | $45,034 | $31,929 | $20,478 | $7,213 | $34,612 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -10,000 | -10,000 | 0 | 0 | -34,725 |
| PPE Investments | -11 | -11 | N/A | N/A | -19 |
| Purchase Of Investment | 5,000 | 5,000 | 5,000 | 5,000 | 71,969 |
| Investing Cash Flow | $-5,011 | $-5,011 | $5,000 | $5,000 | $37,225 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 758 | 693 | 62 | 26 | 1,116 |
| Other Financing Activity | -56 | -17 | 0 | 0 | 0 |
| Financing Cash Flow | $702 | $676 | $62 | $26 | $1,116 |
| Beginning Cash Position | 89,512 | 89,512 | 89,512 | 89,512 | 16,559 |
| End Cash Position | 130,237 | 117,106 | 115,052 | 101,751 | 89,512 |
| Net Cash Flow | $40,725 | $27,594 | $25,540 | $12,239 | $72,953 |
| Free Cash Flow | |||||
| Operating Cash Flow | 45,034 | 31,929 | 20,478 | 7,213 | 34,612 |
| Capital Expenditure | -11 | -11 | 0 | 0 | -19 |
| Free Cash Flow | 45,023 | 31,918 | 20,478 | 7,213 | 34,593 |